These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3287737)

  • 1. Norfenefrine in the treatment of female stress incontinence. A double-blind controlled trial.
    Lose G; Rix P; Diernaes E; Alexander N
    Urol Int; 1988; 43(1):11-5. PubMed ID: 3287737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and urodynamic effects of norfenefrine in women with stress incontinence.
    Lose G; Lindholm P
    Urol Int; 1984; 39(5):298-302. PubMed ID: 6150569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test.
    Diernaes E; Rix P; Sørensen T; Alexander N
    Urol Int; 1989; 44(1):28-31. PubMed ID: 2568712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does medical therapy cure female stress incontinence?
    Lose G; Diernaes E; Rix P
    Urol Int; 1989; 44(1):25-7. PubMed ID: 2568711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of idiopathic orthostatic hypotension with norfenefrine].
    Hengstmann JH
    Med Klin (Munich); 1986 Oct; 81(21):681-4. PubMed ID: 3796505
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute effect of norfenefrine on the urethral pressure profile in females with genuine stress incontinence.
    Jørgensen L; Lose G; Alexander N
    Urol Int; 1991; 46(2):176-9. PubMed ID: 2053226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypotension therapy with norfenefrine--oral administration also dependably effective].
    Fortschr Med; 1983 Aug; 101(30):1386. PubMed ID: 6618400
    [No Abstract]   [Full Text] [Related]  

  • 8. Symptomatic orthostatic essential hypotension Part 2.
    Raij KA
    Br J Clin Pract; 1983 Sep; 37(9):289-94. PubMed ID: 6354235
    [No Abstract]   [Full Text] [Related]  

  • 9. Norfenefrine: haemodynamic effects in healthy volunteers at rest and during orthostasis.
    Magometschnigg D; Stengele E
    Eur J Clin Pharmacol; 1983; 25(2):167-71. PubMed ID: 6628499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Release of norfenefrine from sustained-release formulations by an in vitro dissolution model. Simulation of "drug levels" by calculation using pharmacokinetical constants and comparison with in vivo course of action (author's transl)].
    Laven R; Schäfer EA
    Arzneimittelforschung; 1981; 31(2):353-6. PubMed ID: 7194653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for neuronal uptake and release of norfenefrine and evaluation of its alpha-agonistic effects in the rabbit pulmonary artery.
    Reimann W
    Arzneimittelforschung; 1984; 34(5):575-8. PubMed ID: 6147146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation.
    Fossberg E; Beisland HO; Lundgren RA
    Urol Int; 1983; 38(5):293-9. PubMed ID: 6685364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients.
    Collste L; Lindskog M
    Urology; 1987 Oct; 30(4):398-403. PubMed ID: 3310369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1647-52. PubMed ID: 7197979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study.
    Weil EH; Eerdmans PH; Dijkman GA; Tamussino K; Feyereisl J; Vierhout ME; Schmidbauer C; Egarter C; Kölle D; Plasman JE; Heidler H; Abbühl BE; Wein W
    Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(3):145-50. PubMed ID: 9745973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated modification of the vascular system by vasopressor agents (akrinor, etilefrin, ephedrine, norfenefrine, amezinium) during extracorporeal circulation in man].
    Boldt J; Müller H; Börner U; Kling D; Moosdorf R; Hempelmann G
    Anaesthesist; 1986 Feb; 35(2):93-8. PubMed ID: 2870661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens.
    Sartori MG; Baracat EC; Girão MJ; Gonçalves WJ; Sartori JP; de Lima GR
    Int J Gynaecol Obstet; 1995 May; 49(2):165-9. PubMed ID: 7649322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of urethral closure function in women with stress urinary incontinence.
    Klarskov N; Scholfield D; Soma K; Darekar A; Mills I; Lose G
    J Urol; 2009 Jun; 181(6):2628-33; discussion 2633. PubMed ID: 19375093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
    Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M
    Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distigmine bromide and stress incontinence in women.
    Shah PJ; Abrams PH
    Prog Clin Biol Res; 1981; 78():329-34. PubMed ID: 6121333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.